drugset / Trial / NCT03899064

Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream

NCT03899064

Phase 1 Completed 58 enrolled MC2 Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is a 6-week, Randomized study evaluating the potential of MC2-01 Cream to induce a photoallergic skin reaction in Healthy subjects, using a controlled photopatch test design.

Timeline

Start
2019-02-13
Primary completion
2019-04-05
Completion
2019-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule 0.005 % Topical
Subject betamethasone dipropionate Small molecule 0.064 % Topical